Both in Biotechnology
Ocugen vs Scribe Therapeutics
| Metric | OCGN | SCTX |
|---|---|---|
| Price | $0.9774 | $19.23 |
| Market cap | $331.4M | $364.1M |
| Today | −2.26% | +9.45% |
| 1 month | −8.2% | — |
| 6 months | −47.7% | — |
| Year to date | −27.6% | — |
| 1 year | −44.5% | — |
| Revenue growth (YoY) | +8.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1671.8% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $15.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 68.2% | — |
| Short % of float | 32.8% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).